ONTILYV

This brand name is authorized in Austria, Estonia, Croatia, Ireland, Italy, Lithuania, Poland

Active ingredients

The drug ONTILYV contains one active pharmaceutical ingredient (API):

1 Opicapone
UNII Y5929UIJ5N - OPICAPONE

Opicapone is a peripheral, selective and reversible catechol-O-methyltransferase (COMT) inhibitor endowed with a high binding affinity (sub-picomolar). Opicapone is indicated as adjunctive therapy to preparations of levodopa/DOPA decarboxylase inhibitors (DDCI) in adult patients with Parkinson’s disease, leading to an increase of levodopa plasma levels thereby improving the clinical response to levodopa.

Read about Opicapone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ONTILYV Hard capsule European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N04BX04 N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BX Other dopaminergic agents
Discover more medicines within N04BX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1877283, 1877294, 1877306, 1877317, 1877328, 1877339, 1877340, 1877351, 1877362, 1877373
Country: IT Agenzia del Farmaco Identifier(s): 049963010, 049963022, 049963034, 049963046, 049963059, 049963061, 049963073, 049963085, 049963097, 049963109
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1094285, 1094286, 1094287, 1094288, 1094289, 1094290, 1094291, 1094292, 1094293, 1094294
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100467786, 100467793

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.